Ahmed Mahmoud Bendary
Asst. Professor
Prevalence of Different Etiologies for Heart Failure Among a Contemporary Cohort of Egyptian Patients
Benha Medical Journal • 2024
Publication Information
Authors
Hany H. Ebaid, Ahmed M. Bendary, Diaa M. Zidan,
Osama S. Arafa, Hager I. Allam
Keywords
Prevalence; Etiologies; Heart Failure; Egyptian
Patients
Journal
Benha Medical Journal
Publisher
Egyptian Knowledge Bank
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Open Link
Supplementary Materials
Not Available
Abstract
Background: Heart failure (HF) is a major public health concern
globally and in Egypt. Understanding the prevalence of different
etiologies and management practices in Egyptian HF patients is
crucial for targeted healthcare strategies. This study aimed to
assess the prevalence of different etiologies and management
practices in a contemporary cohort of Egyptian patients with HF.
Methods: This cross-sectional, multi-center observational study
was conducted over 12 months at Agouza Police Hospital and
Benha University Hospital, including 503 Egyptian HF patients.
Data collection involved patient interviews, clinical
examinations, and reviews of medical records and diagnostic
tests. Results: This study comprised 70% males and 30%
females, with an average age of 61 years. The primary etiologies
of HF were ischemic heart disease (68.8%), hypertension (23%),
and valvular heart disease (5.2%). The mean left ventricular
ejection fraction (LVEF) was 45% ± 12. Pharmacological
therapy included ACEIs/ARBs (79.9%), ARNI (10.9%), Betablockers (95.4%), MRAs (86.8%) and SGLT2 inhibitors
(84.9%). A total of 94.4% of patients exhibited ECG
abnormalities, and 34.3% had abnormal chest X-rays.
Conclusion: Ischemic heart disease and hypertension constituted
the most common causes of HF. A significant percentage of
patients received ACEIs/ARBs, Beta-blockers, MRAs, and
SGLT2 inhibitors. The study highlights the need for tailored
management strategies in the Egyptian context, considering the
specific etiological patterns and treatment practices observed.
globally and in Egypt. Understanding the prevalence of different
etiologies and management practices in Egyptian HF patients is
crucial for targeted healthcare strategies. This study aimed to
assess the prevalence of different etiologies and management
practices in a contemporary cohort of Egyptian patients with HF.
Methods: This cross-sectional, multi-center observational study
was conducted over 12 months at Agouza Police Hospital and
Benha University Hospital, including 503 Egyptian HF patients.
Data collection involved patient interviews, clinical
examinations, and reviews of medical records and diagnostic
tests. Results: This study comprised 70% males and 30%
females, with an average age of 61 years. The primary etiologies
of HF were ischemic heart disease (68.8%), hypertension (23%),
and valvular heart disease (5.2%). The mean left ventricular
ejection fraction (LVEF) was 45% ± 12. Pharmacological
therapy included ACEIs/ARBs (79.9%), ARNI (10.9%), Betablockers (95.4%), MRAs (86.8%) and SGLT2 inhibitors
(84.9%). A total of 94.4% of patients exhibited ECG
abnormalities, and 34.3% had abnormal chest X-rays.
Conclusion: Ischemic heart disease and hypertension constituted
the most common causes of HF. A significant percentage of
patients received ACEIs/ARBs, Beta-blockers, MRAs, and
SGLT2 inhibitors. The study highlights the need for tailored
management strategies in the Egyptian context, considering the
specific etiological patterns and treatment practices observed.